CD274 and breast cancer: Therefore, the aim of this study was to perform a comprehensive study of PD-L1 as a biomarker in breast cancer using automated tumour recognition and quantitative IHC image analysis together with objective scoring systems on uniform patient tissue cohorts with extensive clinical annotation.